Table 5 Stratified Analysis of MACE at median Follow-up of 1.98 yr in all enrolled patients divided by the status of TCFA and level of rSS

 without

1(reference)

1.62 (0.64,4.1)

4.13 (1.35,12.61)

1.54 (1.06,2.26)

0.025*

 with

1(reference)

2.48 (0.43,14.38)

1.89 (0.36,10)

4.28 (0.75,24.44)

0.156

 < media

1(reference)

2.93 (0.26,33.31)

0.86 (0.13,5.65)

6.88 (1.37,34.63)

0.088

 ≥ media

1(reference)

0.86 (0.21,3.54)

1.75 (0.68,4.46)

3.09 (0.97,9.83)

0.039

 < 50%

1(reference)

3.69 (0.01,1086.65)

15.65 (0.22,1091.81)

21.82 (0.23,2112.96)

0.113

 ≥ 50%

1(reference)

0.83 (0.21,3.19)

1.33 (0.54,3.27)

3.25 (1.19,8.84)

0.037*

 without

1(reference)

3.65 (0.49,27.06)

4.73 (1.07,20.9)

–

0.019*

 with

1(reference)

0.82 (0.16,4.11)

1.18 (0.43,3.24)

4.11 (1.51,11.19)

0.012*

 without

1(reference)

–

4.94 (1.48,16.5)

10.46 (1.94,56.45)

0.002*

 with

1(reference)

1.08 (0.28,4.23)

0.33 (0.09,1.25)

2.01 (0.62,6.57)

0.826

 without

1(reference)

0.46 (0.06,3.73)

1.97 (0.84,4.6)

4.84 (1.82,12.88)

0.002*

 with

1(reference)

–

–

–

0.986

 < 10

1(reference)

1.76 (0.47,6.66)

1.47 (0.56,3.9)

6.06 (1.87,19.64)

0.017*

 ≥ 10

1(reference)

–

2.29 (0.46,11.5)

3.77 (0.59,23.96)

0.131

 < 300

1(reference)

0.92 (0.17,5.02)

1.54 (0.52,4.61)

7.42 (2.16,25.53)

0.006*

 ≥ 300

1(reference)

4.73 (0.69,32.42)

1.78 (0.5,6.37)

1.02 (0.21,4.94)

0.768

 < 10

1(reference)

3.8 (0.84,17.27)

2.15 (0.7,6.6)

8.37 (2.19,31.99)

0.011*

 ≥ 10

1(reference)

–

2.02 (0.57,7.21)

6.53 (1.37,31.14)

0.027*

 < 300

1(reference)

0.85 (0.22,3.24)

1.34 (0.58,3.13)

4.02 (1.55,10.45)

0.013*

 ≥ 300

1(reference)

14.11 (0.51,388.76)

5.78 (0.11,300.43)

6.95 (0.11,451.72)

0.280

 < media

1(reference)

–

0.72 (0.16,3.35)

4.09 (0.34,49.59)

0.848

 ≥ media

1(reference)

7.18 (0.89,58.24)

2.6 (0.42,16.11)

18.33 (2.92,115.1)

0.005*

 without

1(reference)

0.85 (0.23,3.2)

1.55 (0.68,3.52)

5.6 (2.11,14.87)

0.004*

 with

1(reference)

–

–

–

0.580